Climacteric

Papers
(The median citation count of Climacteric is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
Osteoporosis and fractures in women: the burden of disease94
Hormone replacement therapy – where are we now?67
Three-dimensional bioprinting of artificial ovaries by an extrusion-based method using gelatin-methacryloyl bioink44
CO2 laser and the genitourinary syndrome of menopause: a randomized sham-controlled trial38
The global prevalence of premature ovarian insufficiency: a systematic review and meta-analysis33
The effects of phytoestrogens on postmenopausal health33
Histological findings after non-ablative Er:YAG laser therapy in women with severe vaginal atrophy32
Brain fog in menopause: a health-care professional’s guide for decision-making and counseling on cognition32
Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms – an update on the evidence28
Bone health 2022: an update27
Cardiometabolic health in premature ovarian insufficiency27
Fracture risk assessment by the FRAX model27
Skin, hair and beyond: the impact of menopause24
Endometriosis-associated cancer24
Hormone replacement therapy and cervical cancer: a systematic review of the literature24
Safety of vaginal erbium laser: A review of 113,000 patients treated in the past 8 years24
Premature or early bilateral oophorectomy: a 2021 update24
Menopause and cognitive complaints: are ovarian hormones linked with subjective cognitive decline?22
Selective estrogen receptor modulators and bone health20
Dietary intake and menopausal symptoms in postmenopausal women: a systematic review20
The treatment of menopausal symptoms by traditional Chinese medicine in Asian countries20
Medical treatment of osteoporosis19
Estrogen receptor α: a critical role in successful female cognitive aging17
Cognitive profiles in perimenopause: hormonal and menopausal symptom correlates16
Hyaluronic acid in vulvar and vaginal administration: evidence from a literature systematic review15
Effects of exercise on vasomotor symptoms in menopausal women: a systematic review and meta-analysis14
Health-care providers’ views of menopause and its management: a qualitative study14
Dry eye disease symptoms and quality of life in perimenopausal and postmenopausal women13
Sexual function after vaginal erbium laser: the results of a large, multicentric, prospective study12
A research primer for studies of cognitive changes across the menopause transition12
The 2023 Practitioner’s Toolkit for Managing Menopause12
Effects of non-ablative vaginal erbium:YAG laser treatment for interstitial cystitis/bladder pain syndrome: a case series (UNICORN-2 study)12
A pas de deux of osteoporosis and sarcopenia: osteosarcopenia12
Premenopausal osteoporosis12
Hysteroscopic laser ablation of symptomatic uterine fibroids: insights from a prospective study11
First live birth in China after cryopreserved ovarian tissue transplantation to prevent premature ovarian insufficiency11
Lasers in the era of evidence-based medicine11
Transgender health and the impact of aging and menopause11
Clinical practice of traditional Chinese medicine for the treatment of postmenopausal osteoporosis: a literature review11
Neurokinin 3 receptor antagonists – prime time?10
Menopause, hormone therapy and cognition: maximizing translation from preclinical research10
Postmenopausal hyperandrogenism10
Physiologic and psychosocial changes of the menopause transition in US Latinas: a narrative review10
Premature ovarian insufficiency: the need for evidence on the effectiveness of hormonal therapy10
New insights into the diagnosis and management of bone health in premature ovarian insufficiency10
Novel approaches to fertility restoration in women with premature ovarian insufficiency10
Vaginal collagen I and III changes after carbon dioxide laser application in postmenopausal women with the genitourinary syndrome: a pilot study10
Effects of resistance training on quality of life in postmenopausal women with vasomotor symptoms10
Menopausal hormone therapy: why we should no longer be afraid of the breast cancer risk9
Does the environment affect menopause? A review of the effects of endocrine disrupting chemicals on menopause9
Vaginal laser therapy for GSM/VVA: where we stand now – a review by the EUGA Working Group on Laser9
Precision hormone therapy: identification of positive responders9
PGRMC1 promotes triple-negative breast cancer cell growth via suppressing ferroptosis9
Update on bone health: the International Menopause Society White Paper 20219
Association of bilateral oophorectomy and menopause hormone therapy with mild cognitive impairment: the REDLINC X study9
The effects of hormone replacement therapy on the microbiomes of postmenopausal women9
First pregnancy in China after ovarian tissue transplantation to prevent premature ovarian insufficiency9
The impact of cannabis use on vasomotor symptoms, mood, insomnia and sexuality in perimenopausal and postmenopausal women: a systematic review8
The severe acute respiratory syndrome due to coronavirus 2 (SARS-CoV-2) infection and the climacteric woman8
Short-term effects of an erbium/neodymium laser combination in superficial dyspareunia: a pilot study8
Sustainability of vaginal estrogens for genitourinary syndrome of menopause – a systematic review8
Impact of estetrol (E4) on hemostasis, metabolism and bone turnover in postmenopausal women8
Safety of prasterone in breast cancer survivors treated with aromatase inhibitors: the VIBRA pilot study8
Reproductive milestones across the lifespan and cardiovascular disease risk in women8
Relationship between the type of hormone replacement therapy and incidence of breast cancer in Korea8
Fracture recurrence in hip fracture with menopausal hormone therapy versus risedronate: a clinical trial7
Bioidentical hormones7
Associations between WNT signaling pathway-related gene polymorphisms and risks of osteoporosis development in Chinese postmenopausal women: a case–control study7
Peer review: the cornerstone of scientific publishing integrity7
Osteoanabolic therapy for osteoporosis in women7
Polycystic ovary syndrome: associations with cardiovascular disease7
Quality of life in menopausal women in the workplace – a systematic review7
The impact of micronized progesterone on cardiovascular events – a systematic review7
Premature ovarian insufficiency: a toolkit for the primary care physician7
Association of menopausal status and symptoms with depressive symptoms in middle-aged Chinese women7
The role of estrogens in osteosarcopenia: from biology to potential dual therapeutic effects7
Hormone therapy for postmenopausal osteoporosis management7
Understanding of and clinical approach to cardiometabolic transition at the menopause7
Vulvodynia – an evolving disease6
Evaluation of the relationship between homocysteine levels and bone mineral density in postmenopausal women6
Relationship between vasomotor symptoms and metabolic syndrome in Chinese middle-aged women6
Use of MHT in women with cardiovascular disease: a systematic review and meta-analysis6
Er:YAG laser in hysterectomized women with stress urinary incontinence: a VELA retrospective cohort, non-inferiority study6
Interactions between estradiol, diabetes, and brain aging and the risk for cognitive impairment6
Treatment indications and thresholds of intervention: consensus and controversies in osteoporosis6
Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA6
Changes in high-sensitivity C-reactive protein levels and metabolic indices according to grip strength in Korean postmenopausal women6
International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women6
Compounded bioidentical menopausal hormone therapy – a physician perspective6
Effects of ospemifene on overactive bladder in postmenopausal women with vulvovaginal atrophy6
Pulmonary embolism in menopausal hormone therapy: a population-based register study6
Resveratrol promotes bone mass in ovariectomized rats and the SIRT1 rs7896005 SNP is associated with bone mass in women during perimenopause and early postmenopause6
Sequential treatment in vulvovaginal atrophy6
Testosterone for women: certainties and uncertainties6
Impact of progesterone on the gastrointestinal tract: a comprehensive literature review6
Pelvic floor muscle rehabilitation for genitourinary syndrome of menopause: why, how and when?6
Treating genitourinary syndrome of menopause in breast cancer survivors: main challenges and promising strategies6
Weight gain in menopause: systematic review of adverse events in women treated with black cohosh6
E2 + norethisterone promotes the PI3K–AKT pathway via PGRMC1 to induce breast cancer cell proliferation6
Effect of external sleep disturbance on sleep architecture in perimenopausal and postmenopausal women5
Xiangshao granules can relieve emotional symptoms in menopausal women: a randomized controlled trial5
Androgens in premenopausal women and women with premature ovarian insufficiency5
Primary choice of estrogen and progestogen as components for HRT: a clinical pharmacological view5
Postmenopausal women’s cognitive function and performance of virtual reality tasks5
Fat mass, weight and body shape changes at menopause – causes and consequences: a narrative review5
Menopause and diabetes5
Women and COVID-19: severity and mortality in hospitalized middle-aged and older patients5
Evidence synthesis in the time of COVID-195
Impact of progesterone on skin and hair in menopause – a comprehensive review5
Menopausal hormone therapy and coronary heart disease: the roller-coaster history5
The impact of menopause education on quality of life among menopausal women: a systematic review with meta-analysis5
Premature ovarian insufficiency – the need for a genomic map5
Prediction of premature ovarian insufficiency: foolish fallacy or feasible foresight?5
Genitourinary syndrome of menopause in Chinese perimenopausal and postmenopausal women5
Glycyrrhizin improves bone metabolism in ovariectomized mice via inactivating NF-κB signaling5
Ultra-low-dose estradiol and dydrogesterone: a phase III study for vasomotor symptoms in China4
Estradiol selectively regulates metabolic substrates across memory systems in models of menopause4
Fezolinetant for the treatment of vasomotor symptoms associated with menopause: a meta-analysis4
Prevalence of mild cognitive impairment in surgical menopause: subtypes and associated factors4
The promotion of menopausal hormone therapy might be determined by the attitude of health-care professionals4
What is in a name? A decade after changing from VVA to GSM have we come any closer to ending the ‘silent suffering’ of postmenopausal women with genitourinary symptoms?4
Postmenopausal women’s adherence to pelvic floor muscle exercises over 2 years4
Vasomotor symptoms and cardiovascular health: findings from the SWAN and the MsHeart/MsBrain studies4
Relation between blood pressure and genito-urinary symptoms in the years across the menopausal age4
Efficacy of low-dose vaginal 17β-estradiol versus vaginal promestriene for vulvovaginal atrophy4
It starts from the womb: maximizing bone health4
Genistein for glycolipid metabolism in postmenopausal women: a meta-analysis4
Overexpression of miR-181a regulates the Warburg effect in triple-negative breast cancer4
A pilot screening study for low bone mass in Singaporean women using years since menopause and BMI4
Alterations of regional homogeneity in perimenopause: a resting-state functional MRI study4
Profile of Brazilian climacteric women: results from the Brazilian Menopause Study4
Different local estrogen therapies for a tailored approach to GSM4
SUI in postmenopausal women: advantages of an intraurethral + intravaginal Er:YAG laser4
Evaluation and management of endometriosis4
Depression in midlife women attending a menopause clinic is associated with a history of childhood maltreatment4
Breast cancer therapy and bone4
Progress in understanding and management of premature ovarian insufficiency4
Premature ovarian insufficiency and autoimmune profiles: a prospective case–control study4
Are we assessing genitourinary syndrome of menopause properly?4
Swiss consensus on the role of DHEA in the management of genitourinary syndrome of menopause4
Menopausal hormonal therapy in surgically menopausal women with underlying endometriosis4
Evaluating the menopausal transition with the STRAW + 10 in a Brazilian cohort of women with HIV, 2015–20164
Effect of surgical menopause and frontal lobe cognitive function4
A bibliometric analysis of primary ovarian insufficiency from 2010 to 20204
The heat is on3
Bone-friendly lifestyle and the role of calcium or vitamin D supplementation3
Hormone therapy effect on menopausal systemic lupus erythematosus patients: a systematic review3
The rs2165241 polymorphism of the Loxl1 gene in postmenopausal women with pelvic organ prolapse3
Scientific insights into brain fog during the menopausal transition3
Differences in patient-reported hormone therapy use for menopause symptoms by provider specialty3
A disease of her own? Unique features of heart failure in women3
Vulvovaginal atrophy management with a laser: the placebo effect or the conditioning Pavlov reflex3
Marketing the menopause3
A review of the impact of hormone therapy on prefrontal structure and function at menopause3
The role of medications in successful aging3
Menopause care delivery in the time of COVID-19: evaluating the acceptability of telehealth services for women with early and usual age menopause3
Efficacy of intradermal hyaluronic acid plus polynucleotides in vulvovaginal atrophy: a pilot study3
Expert opinion on the treatment of vulvovaginal atrophy with ospemifene based on new evidence3
Risk of endometrial malignancy in women treated for breast cancer: the BLUSH prediction model – evidence from a comprehensive multicentric retrospective cohort study3
The yin and yang of GSM and low sexual desire3
Estrone, sex hormone binding globulin and lipid profiles in older women: an observational study2
The mediating role of socioeconomic status on the relationship between pregnancy history and later-life cognition2
IGF-1R/β-catenin signaling axis is implicated in streptozotocin exacerbating bone impairment in ovariectomized rats2
Pharmacokinetics, safety and preliminary pharmacodynamic evaluation of DARE-VVA1: a soft gelatin capsule containing tamoxifen for the treatment of vulvovaginal atrophy2
Use of interventions involving virtual reality tasks during the climacteric: a systematic review2
Menopause status and climacteric symptoms in a birth cohort of mid-life New Zealand women2
Global view of vasomotor symptoms and sleep disturbance in menopause: a systematic review2
Validation of a clinical tool for vestibular trophism in postmenopausal women2
Lichen sclerosus of the vulva2
Effect of hormone replacement therapy on intervertebral disc height2
Association between testosterone and cognitive performance in postmenopausal women: a systematic review of observational studies2
The WHO claims estrogens are ‘carcinogenic’: is this true?2
Early decrease in lean mass and bone mass in postmenopausal women: a cross-sectional study2
Using menopausal hormone therapy to prevent fracture recurrence in older women: is it time to change our opinion?2
Long-term clinical and histological safety and efficacy of the CO 2 laser for treatment of genitourinary syndrome of menopause: an original study2
‘Vaginal Laser Therapy for GSM/VVA: Where We Stand Now – A Review by the EUGA Working Group on Laser’2
Effect of estrogen on vaginal complications of pessary use: a systematic review and meta-analysis2
Association between coronary artery vitamin D receptor expression and select systemic risks factors for coronary artery atherosclerosis2
Primary prevention of cardiovascular disease in women2
Impact of overweight and obesity in postmenopausal women2
Longitudinal relationships between self-compassion and depressive symptoms in midlife women2
Recent advances in the management of postmenopausal women with non-atypical endometrial hyperplasia2
Clinical impact of misinterpretation of dual-energy X-ray absorptiometry during the evaluation of osteoporotic patients2
Estrogen as a guardian of auditory health: Tsp1–CD47 axis regulation and noise-induced hearing loss2
Effect of menopausal symptom treatment options on palpitations: a systematic review2
Pregnancy-associated risk factors for future cardiovascular disease – early prevention strategies warranted2
Urinary incontinence as a marker of temporality in women: a qualitative study2
Impacts of menopause hormone therapy on mood disorders among postmenopausal women2
Peer review? No thanks!2
God, spirituality and religion in women dying from gynecological cancer2
Menopausal hormone therapy: what are the problems in the perception of Chinese physicians?2
The role of microbiota in the management of genitourinary syndrome of menopause2
Vaginal dryness: a review of current understanding and management strategies2
Women’s cardiovascular health – the cardio-oncologic jigsaw2
Menopause, aging and the failing pelvic floor: a clinician’s view2
Menopause symptoms, sexual dysfunctions and pelvic floor disorders in refugee and asylum seeker women: a scoping review2
Impact of age and menopausal stage on serum anti-Müllerian hormone levels in middle-aged women2
Breast cancer genetics and risk assessment: an overview for the clinician2
Determinants of attained estradiol levels in response to oral estradiol plus progesterone therapy2
Testosterone and the heart: friend or foe?2
Diagnosis and medical management of abnormal premenopausal and postmenopausal bleeding2
Ischemia but no obstructive coronary artery disease: more than meets the eye2
Use of a vaginal CO2 laser for the management of genitourinary syndrome of menopause in gynecological cancer survivors: a systematic review2
FNDC5/Irisin polymorphisms are associated with osteopenia in postmenopausal Mayan-Mestizo women2
Associations of fat mass index with hot flashes and lean mass index with insomnia in middle-aged women2
0.037981033325195